Positive inotropic effects of the calcium sensitizer CGP 48506 in guinea pig myocardium1

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1572-1578

  Zimmermann, Norbert ^b   Bokni, Peter ^d   Gams, Emmeran ^c   Herzig, Joachim W ^e,f,g   Neumann, Joachim ^a   Schmitz, Wilhelm ^a   Scholz, Hasso ^b   Wenzlaff, Holger ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d Kat Farmakoiógie a Toxikol   (Slovakia)

^e CIBA GEIGY LTD   (Switzerland)

^f F HOFFMANN LA ROCHE LTD   (Switzerland)

^g AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5,6 TETRAHYDRO 5 METHYL 6 PHENYL 3,6 METHANO 1,5 BENZODIAZOCINE 2,4 DIONE; 5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; ADENOSINE DEAMINASE; CALCIUM CHANNEL; CALCIUM SENSITIZER; CYCLIC AMP; ISOBUTYLMETHYLXANTHINE; OKADAIC ACID; PHOSPHODIESTERASE I; PHOSPHODIESTERASE IV; PHOSPHORYLASE PHOSPHATASE; PIMOBENDAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENANTIOMER; ENZYME ACTIVITY; GUINEA PIG; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE TENSION; HEART PAPILLARY MUSCLE; HEART VENTRICLE CONTRACTION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKINNED MUSCLE FIBER;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; AZOCINES; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART; KINETICS; MUSCLE CONTRACTION;

EID: 0030435126     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AHMAE, Z., GREEN, F. J., SUBUHI, H. S. AND WATANABE, A. M.: Autonomic regulation of type 1 protein phosphatase in cardiac muscle. J. Biol. Chem. 264: 3859-3863, 1989.
2. BAUER, A. C. AND SCHWABE, U.: An improved assay of cyclic 3',5'-nucleotide phoephodiesterases with QAE-Sephadex columns. Naunyn Schmiedeberg's Arch. Pharmacol. 311: 193-198, 1980.
3. BETHKE, T., BRUNKHORST, D., VON DER LEYEN, H., MEYER, W., NIGBUR, R. AND SCHOLZ, H.: Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts. Naunyn Schmiedeberg's Arch. Pharmacol. 337: 576-582, 1988.
4. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
5. BRISTOW, M. R., GINSBURG, R., MINOBE, W., CUBICCIOTTI, R. S., SAGEMAN, W. S., LURIE, K., BILLINGHAM, M. E., HARRISON, D. C. AND STINSON, E. B.: Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. New Engl. J. Med. 307: 205-211,1982.
6. BRUNKHORST, D., VON DER LEYEN, H., MEYER, W., NIGBUR, R., SCHMIDTSCHUMACHER, C. AND SCHOLZ, H.: Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart. Naunyn Schmiedeberg's Arch. Pharmacol. 339: 575-583, 1989.
7. ENDOH, M.: The time course of changes in cyclic nucleotide levels during cholinergic inhibition of positive inotropic actions of isoprenaline and theophylline in the isolated canine ventricular myocardium. Naunyn Schmiedeberg'e Arch. Pharmacol. 312: 175-182, 1980.
8. FABIATO, A.: Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplaemic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J. Gen. Physiol. 78: 457-497, 1981.
9. FELDMAN, A. M., COPELAS, L., GWATHMEY, J. K., PHILLIPS, P., WARREN, S. E., SCHOEN, F. J., GROSSMAN, W. AND MORGAN, J. P.: Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75: 331-339, 1987.
10. 2+ activation and the inotropic effect of pimobendan: Comparison with milrinone. Circ. Res. 63: 911-917, 1988.
11. GUPTA, R. C., NEUMANN, J. AND WATANABE, A. M.: Comparison of purinergic and muscarinic receptor mediated effects on phosphatase inhibitor-1 activity in the heart. J. Pharmacol. Exp. Ther. 266: 16-22, 1993.
12. HEROLD, P., HERZIG, J. W., WENK, P., LEUTERT, T., ZBINDEN, P., FUHRER, W., STUTZ, S., SCHENKER, K., MEIER, M. AND RIHS, G.: 5-methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione (BA 41899): Representative of a novel class of purely calcium-sensitizing agents. J. Med. Chem. 38: 2946-2954, 1995.
13. max) in isolated contractile structures from mammalian heart muscle. Arzneim.-Forsch/Drug Res. 31: 188-191, 1981.
14. KORTH, M.: Effects of several phosphodiesterase inhibitors on guinea-pig myocardium. Naunyn Schmiedebergs Arch. Pharmacol. 302: 77-86, 1978.
15. 4. Nature (Lond.) 227: 680-685, 1970.
16. 2+-sensitizing agent. Pflüger's Arch. Eur. J. Physiol. 421: 388-390, 1992.
17. 2+ transport in guinea-pig ventricles. J. Biol. Chem. 260: 13122-13129, 1985.
18. LUES, I., BEIER, N., JONAS, R., KLOCKOW, M. AND HAEUSLBR, G.: The two mechanisms of action of the racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J. Cardiovasc. Pharm. 21: 883-892, 1993.
19. NEUMANN, J., GUPTA, R. C., SCHMITZ, W., SCHOLZ, H., NAIRN, A. C. AND WATANABE, A. M.: Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ. Res. 69: 1450-1457, 1991.
20. NEUMANN, J., BOKNIK, P., HERZIG, S., SCHMITZ, W., SCHOLZ, H., GUPTA, R. C. AND WATANABE, A. M.: Evidence of physiological functions of protein phosphatases in the heart. Evaluation with okadaic acid. Am. J. Physiol. 265: H257-H266, 1993.
21. NEUMANN, J., BOKNIK, P., BODOR, G. S., JONES, L. R., SCHMITZ, W. AND SCHOLZ, H.: Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin. J. Pharmacol. Exp. Ther. 269: 1310-1318, 1994a.
22. NEUMANN, J., BOKNIK, P., HERZIG, S., SCHMITZ, W., SCHOLZ, H., WIECHEN, K AND ZIMMERMANN, N.: Biochemical and electrophysiological mechanisms of the positive inotropic effects of calyculin A, a protein phosphatase inhibitor. J. Pharmacol. Exp. Ther. 211: 535-541, 1994b.
23. NEUMANN, J., BOKNIK, P., SCHMITZ, W., SCHOLZ, H. AND ZIMMERMANN, N.: Comparison of the stereoselective effects of a thiadiazinone derivative on contractile parameters and protein phosphorylation in the mammalian ventricle. J. Cardiovasc. Pharmacol. 25: 789-793, 1995.
24. NEUMANN, J., ESCHENHAGEN, T., GRUPP, I. L., HAVERICH, A., HERZIG, J. W., HIRT, S., KALMAR, P., SCHMITZ, W., SCHOLZ, H., STEIN, B., WENZLAFF, H. AND ZIMMERMANN, N.: Positive inotropic effects of the calcium sensitizer CGP 48506 in failing human myocardium. J. Pharmacol. Exp. Ther. 277: 1579-1585, 1996.
25. PERRIN, D. D. AND SAYCE, I. G.: Computer calculation of equilibrium concentrations in mixtures of metal ions and complexing species. Talanta 14: 833-842, 1967.
26. RAPUNDALO, S. T., SOLARO, R. J. AND KRANIAS, E. G.: Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea-pig hearts: Comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins. Circ. Res. 64: 104-111, 1989.
27. REEVES, M. L., LEIGH, B. K. AND ENGLAND, P. J.: The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Biochem. J. 241: 535-341, 1987.
28. SCHOLZ, H.,MENDE, U., NEUMANN, J., SCHMITZ, W., SCHOLZ, J. AND STEINFATH, M.: Regulation of EC-coupling by drugs and receptors. Alpha-adrenoceptors. J. Mol. Cell. Cardiol. 24: suppl. II, 27-36, 1992.
29. THOMPSON, W. J. AND APPLEMAN, M. M.: Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10: 311-319, 1971.
30. WILMSHURST, P. T., WALKER, J. M., FRY, C. H., MOUNSEY, J. P., TWORT, C. H. C., WILLIAMS, B. T., DAVIES, M. J. AND WEBB-PEPLOE, M. M.: Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc. Res. 18: 302-307, 1984.